Beta-carotene and cancer prevention: the Basel Study

Area of Science:

• Nutritional Epidemiology
• Oncology
• Preventive Medicine

Background:

• The Basel Study, initiated in 1959, is a long-term epidemiological research project.
• Antioxidant vitamins and carotene play crucial roles in cellular protection.
• Understanding the relationship between nutrient intake and cancer risk is vital for public health.

Purpose of the Study:

• To investigate the association between plasma levels of antioxidant vitamins and carotene and the risk of developing various cancers.
• To determine if low carotene levels predict an increased risk of specific cancer types.

Main Methods:

• Plasma levels of antioxidant vitamins and carotene were measured in 2974 men during a 1971-1973 examination.
• A 12-year observation period (1973-1985) tracked cancer incidence and mortality in the study cohort.
• Cox's proportional hazards model was used to assess relative risks associated with low nutrient levels.

Main Results:

• Significantly lower mean carotene levels were observed in men who died from all cancers, lung cancer, and stomach cancer compared to survivors.
• Low plasma carotene (< 0.23 mumol/L) was significantly associated with an elevated risk of lung cancer.
• Combined low levels of carotene and retinol were linked to a higher overall cancer risk.

Conclusions:

• Low plasma carotene, indicative of reduced dietary intake, is associated with an increased risk of cancer.
• Carotene and potentially other antioxidant vitamins may play a protective role against cancer development.
• These findings underscore the importance of adequate carotene consumption for cancer prevention strategies.